MedTrace Logo

Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population

NCT05902871 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-19

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and effectiveness of Direct Selective Laser Trabeculoplasty (DSLT) in ethnic Chinese participants with Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT), or Normal Tension Glaucoma (NTG).

Conditions

Interventions

DEVICE

External Automatic Glaucoma Laser

Trans-limbal, direct selective laser trabeculoplasty (DSLT) instrument that directs laser energy through the sclera around the limbus overlying the trabecular meshwork and treats 360 degrees of the angle is treated simultaneously

PROCEDURE

Direct Selective Laser Trabeculoplasty

Surgical procedure that utilizes a laser to improve fluid drainage in the eye and reduce intraocular pressure

Sponsors & Collaborators

  • BelkinVision

    lead INDUSTRY

Principal Investigators

  • Dorit Raz Prag · Alcon Research, LLC

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-11
Primary Completion
2026-07-31
Completion
2027-01-31

Countries

  • China
  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05902871 on ClinicalTrials.gov